Synthesis of Biotinylated Galiellalactone Analogues
- 1 Centre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden
- 2 Division of Urological Cancers, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
- 3 Division of Urological Cancers, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
- 4 Division of Urological Cancers, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
- 5 Centre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden
Abstract
Two biotinylated derivatives of the fungal metabolite galiellalactone (1) were synthesized in order to facilitate the investigation of the molecular mechanism of action of the galiellalactonoids. Galiellalactone is a STAT3-signaling inhibitor that inhibits growth in vitro as well as in vivo of prostate cancer cells expressing activated STAT3. To provide a suitable point of attachment for biotin, the 8-hydroxymethyl derivative (3) and its 7-phenyl analogue 4 were synthesized by a modified tandem Pd-catalysed carbonylation and intramolecular vinyl allene Diels-Alder procedure previously developed. The two primary alcohols obtained, 3 and 4, were coupled to biotin as the 6-aminohexanoic acid amide, activated as the acid chloride, yielding the derivatives 5 and 6.
- Peyser, N.D. and Grandis, J.R. (2013) Critical Analysis of the Potential for Targeting STAT3 in Human Malignancy. Journal of OncoTargets and Therapy, 6, 999-1010. http://dx.doi.org/10.1002/jcp.10364
- Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N. and Russo, A. (2003) STAT Proteins: From Normal Control of Cellular Events to Tumorigenesis. Journal of Cellular Physiology, 197, 157-168.
- Shodeinde, A.L. and Barton, B.E. (2012) Potential Use of STAT3 Inhibitors in Targeted Prostate Cancer Therapy: Future Prospects. OncoTargets and Therapy, 5, 119-125.
- Hellsten, R., Johansson, M., Dahlman, A., Sterner, O. and Bjartell, A. (2008) Galiellalactone is a Novel Therapeutic Candidate against Hormone-Refractory Prostate Cancer Expressing Activated Stat3. Prostate, 68, 269-280. http://dx.doi.org/10.1002/pros.20699
- Hellsten, R., Johansson, M., Dahlman, A., Sterner, O. and Bjartell, A. (2011) Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells. PLoS One, 6, e22118. http://dx.doi.org/10.1371/journal.pone.0022118
- Don-Doncow, N., Escobar, Z., Johansson, M., Kjellstrom, S., Garcia, V., Munoz, E., Sterner, O., Bjartell, A. and Hellsten, R. (2014) Galiellalactone Is a Direct Inhibitor of STAT3 in Prostate Cancer Cells. Journal of Biological Chemistry, 289, 15969-15978. http://dx.doi.org/10.1074/jbc.M114.564252
- Johansson, M. (2002) Biosynthetic and SyntheticStudies of the Fungal Metabolite Gliellalactone. Ph.D. Dissertation, Bioorganic Chemistry, Lund University, Lund.
- Gidlof, R., Johansson, M. and Sterner, O. (2010) Tandem Pd-Catalyzed Carbonylation and Intramolecular Vinyl Allene Diels-Alder Reaction toward Galiellalactone Analogues. Organic Letters, 12, 5100-5103. http://dx.doi.org/10.1021/ol101989m
- Johansson, M., and Sterner, O. (2001) Synthesis of (+)-Galiellalactone. Absolute Configuration of Galiellalactone. Organic Letters, 3, 2843-2845. http://dx.doi.org/10.1021/ol016286+
- Johansson, M. and Sterner, O. (2002) Synthesis of (-)-Galiellalactone. The Journal of Antibiotics, 55, 663-665.
- Von Nussbaum, F., Hanke, R., Fahrig, T. and Benet-Buchholz, J. (2004) The High-Intrinsic Diels-Alder Reactivity of (-)-Galiellalactone; Generating Four Quaternary Carbon Centers under Mild Conditions. European Journal of Organic Chemistry, 2004, 2783-2790. http://dx.doi.org/10.1002/ejoc.200400137
- Best, M.D. (2009) Click Chemistry and Bioorthogonal Reactions: Unprecedented Selectivity in the Labeling of Biological Molecules. Biochemistry, 48, 6571-6584. http://dx.doi.org/10.1021/bi9007726